In the pharmaceutical industry, an intermediate is a chemical compound that is produced during the various stages of drug manufacturing. These intermediates are not intended for direct therapeutic use but play a vital role in the synthesis of active pharmaceutical ingredients (APIs). Through a series of controlled chemical reactions, intermediates are transformed into APIs, which are then formulated into final dosage forms such as tablets, capsules, or injections. Pharmaceutical intermediates must meet strict quality, purity, and regulatory standards because any impurity can affect the safety and effectiveness of the final medicine. They are carefully designed to ensure efficiency, consistency, and scalability in drug production. By enabling complex chemical synthesis in a step-by-step manner, pharmaceutical intermediates help manufacturers develop reliable, cost-effective, and high-quality medicines that meet global healthcare needs.
| Product Name | Short Name | CAS No | USED API Name | Regulatory Approval | Enquiry |
|---|---|---|---|---|---|
| 3-pyridlacetic acid hydrochloride | Pah | 6419-36-9 | Risedronate sodium | Tip | |
| 3-pyridlacetic acid | Paa | 501-81-5 | Risedronate sodium | Tip | |
| N-(4-cyanophenyl) glycine | Cpg | 42288-26-6 | Dabigatran | Tip | |
| 1-(2-ethoxyethyl)-2-(piperidin-4-yl)-1h-benzo[d]imidazole | Bilastine its | 1841081-72-1 | Bilastine | Tip | |
| Etodolac methyl ester | Eme | 122188-02-7 | Etodolac | Tip | |
| 2-chloro-3,4-bis((4-methoxybenzyl)oxy)benzoic acid | Ceb-4 | 137054-46-7 | Cefiderocol | Tip | |
| 2-chloro-3,4-bis((4-methoxyphenyl)methoxy)benzaldehyde | Ceb-3 | 1884263-19-1 | Cefiderocol | Tip | |
| 2-chloro-3,4-bis((4-methoxy)-n-(2-pyrrolidin-1-ylethyl)benzamide | Ceb-5 | 1225208-44- | Cefiderocol | Tip | |
| 6-fluoro-3-(4-piperidinyl)-1,2-benzisoxazole hydrochloride | Benzisoxazo | 84163-13-3 | Paliperidone & risperidone | Tip |